Pliant Therapeutics, Inc. (PLRX)
NASDAQ·Healthcare·Biotechnology
$0.87
+2.27%
Mkt Cap $65.64M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+245.2%
Consensus $3.00 vs current $0.87
NASDAQ·Healthcare·Biotechnology
$0.87
+2.27%
Mkt Cap $65.64M
No recent rating data.
Price Target (11 analysts)
$3.00
Range $3.00 – $3.00
+245.2%
Consensus $3.00 vs current $0.87